Full Text
HPR67 Canada’s Evolving Market for Biosimilars and What It Means for Payers

Abstract

Authors

Yvonne Zhang

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×